Results
1 -
10 of
1186Ruggero Angelico, Luigi Ambrosone, Andrea Ceglie, Ilario Losito, Giovanna De Zio and Francesco Palmisano.
Complementary amphiphilic ribonucleotides confined into nanostructured environments, Phys. Chem. Chem. Phys., 2010, 12, 7977. Yuen-Jen Wu, Chen-Chieh Liao, Cheng-Hung Jen, Yu-Chiao Shih and Tun-Cheng Chien.
Chemical models and their mechanistic implications for the transformation of 6-cyanouridine 5′-monophosphate catalyzed by orotidine 5′-monophosphate decarboxylase, Chem. Commun., 2010, 46, 4821. Wickliffe O. WepukhuluCurrent address: Merck and Co., Inc., West Point, PA, USA., Vanessa L. SmileyCurrent address: Panacea Pharmaceuticals, Gaithersburg, MD, USA. ., Bhargavi VemulapalliCurrent address: MedImmune, Gaithersburg, MD, USA., Jeffrey A. SmileyPermanent address: American Chemical Society, Petroleum Research Fund, 1155 Sixteenth St. NW, Washington, DC 20036, USA., Linda M. Phillips and Jeehiun K. Lee.
A substantial oxygen isotope effect at O2 in the OMP decarboxylase reaction: Mechanistic implications, Org. Biomol. Chem., 2008, 6, 4533. El-Tayeb A; Qi A; M?ller CE.
Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors., Journal of medicinal chemistry Kortylewicz ZP; Kimura Y; Inoue K; Mack E; Baranowska-Kortylewicz J.
Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation., Journal of medicinal chemistry Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP.
Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics., Journal of medicinal chemistry